Sustained-release from nanocarriers: A review

Journal of Controlled Release

Volumn 193, Issue , 2014, Pages 122-138

  Natarajan, Jayaganesh V ^a   Nugraha, Chandra ^a   Ng, Xu Wen ^a   Venkatraman, Subbu ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Drug delivery; Localized drug release; Nanocarriers; Sustained drug release; Targeting

Indexed keywords

DRUG RELEASE; NANO-CARRIERS; SUSTAINED DRUG RELEASE; SUSTAINED-RELEASE; TARGETING;

DRUG DELIVERY;

DOXORUBICIN; LIPOSOME; NANOCARRIER; NANOPARTICLE; POLYELECTROLYTE NANOPARTICLE; POLYMER; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; DRUG CARRIER; MICELLE;

ARTICLE; CANCER CHEMOTHERAPY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; GLASS TRANSITION TEMPERATURE; HUMAN; HYDROPHILICITY; LIPOPHILICITY; MACROMOLECULE; NANOENCAPSULATION; PARTICLE SIZE; PHASE TRANSITION; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMICAL PHENOMENA; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG RELEASE; MICELLE; PHARMACOKINETICS; TISSUE DISTRIBUTION;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG LIBERATION; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOSOMES; MICELLES; NANOPARTICLES; TISSUE DISTRIBUTION;

EID: 84908302572     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.05.029     Document Type: Article

References (140)

1. C.J. Hitzman, T.S. Wiedmann, H. Dai, and W.F. Elmquist Measurement of drug release from microcarriers by microdialysis J. Pharm. Sci. 94 2005 1456 1466
2. I. Henriksen, S.A. Sande, G. Smistad, T. Agren, and J. Karlsen In-vitro evaluation of drug-release kinetics from liposomes by fractional dialysis Int. J. Pharm. 119 1995 231 238
3. N. Chidambaram, and D.J. Burgess A novel in vitro release method for submicron-sized dispersed systems AAPS PharmSci 1 1999
4. G. Shazly, T. Naworth, and P. Langguth Comparison of dialysis and dispersion methods for in vitro release determination of drugs from multilamellar liposomes Dissolution technologies 2008 1 4
5. S.S. D'Souza, and P.P. DeLuca Methods to assess in vitro drug release from injectable polymeric particulate systems Pharm. Res. 23 2006 460 474
6. C. Washington Drug release from microdisperse systems: a critical review Int. J. Pharm. 58 1990 1 12
7. M.M. Abdel-Mottaleb, and A. Lamprecht Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I Drug Dev. Ind. Pharm. 37 2011 178 184
8. Y. Gao, J. Zuo, N. Bou-Chacra, T.d.J.A. Pinto, S.-D. Clas, R.B. Walker, and R. Lobenberg In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus BioMed Res. Int. 2013 2013 9
9. N. Charalampopoulos, K. Avgoustakis, and C.G. Kontoyannis Differential pulse polarography: a suitable technique for monitoring drug release from polymeric nanoparticle dispersions Anal. Chim. Acta. 491 2003 57 62
10. P. Jara-Ulloa, P. Salgado-Figueroa, C. Yañez, L.J. Núñez-Vergara, and J.A. Squella Voltammetric determination of nifedipine on carbon nanotubes-modified glassy carbon electrode: A new application to dissolution test studies Electroanalysis 24 2012 1751 1757
11. A. Lamprecht, P. Saulnier, F. Boury, C. Passirani, J.E. Proust, and J.P. Benoit A quantitative method for the determination of amphiphilic drug release kinetics from nanoparticles using a Langmuir balance Anal. Chem. 74 2002 3416 3420
12. V. Wagner, A. Dullaart, A.-K. Bock, and A. Zweck The emerging nanomedicine landscape Nat. Biotechnol. 24 2006 1211 1217
13. J.K. Vasir, and V. Labhasetwar Biodegradable nanoparticles for cytosolic delivery of therapeutics Adv. Drug Deliv. Rev. 59 2007 718 728
14. R. Duncan, and R. Gaspar Nanomedicine(s) under the microscope Mol. Pharm. 8 2011 2101 2141
15. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 1986 6387 6392
16. N.J. Robert, C.L. Vogel, I.C. Henderson, J.A. Sparano, M.R. Moore, P. Silverman, B.A. Overmoyer, C.L. Shapiro, J.W. Park, G.T. Colbern, E.P. Winer, and A.A. Gabizon The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer Semin. Oncol. 31 Supplement 13 2004 106 146
17. M.A. Phillips, M.L. Gran, and N.A. Peppas Targeted nanodelivery of drugs and diagnostics Nano Today 5 2010 143 159
18. M.R. Green, G.M. Manikhas, S. Orlov, B. Afanasyev, A.M. Makhson, P. Bhar, and M.J. Hawkins Abraxane, a novel cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer Ann. Oncol. 17 2006 1263 1268
19. E. Miele, G.P. Spinelli, E. Miele, F. Tomao, and S. Tomao Albumin-bound formulation of paclitaxel (Abraxane(r) ABI-007) in the treatment of breast cancer Int. J. Nanomedicine 4 2009 99 105
20. H. Okada One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate Adv. Drug Deliv. Rev. 28 1997 43 70
21. Yun-Seok Rhee, Chun-Woong Park, Patrick P. DeLuca, and H.M. Mansour Sustained-release injectable drug delivery Pharm. Technol. 2010 s6 s13
22. T.M. Allen, and P.R. Cullis Liposomal drug delivery systems: From concept to clinical applications Adv. Drug Deliv. Rev. 65 2013 36 48
23. Y. Barenholz Doxil(r) - The first FDA-approved nano-drug: lessons learned J. Control. Release 160 2012 117 134
24. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton, and V. Préat PLGA-based nanoparticles: an overview of biomedical applications J. Control. Release 161 2012 505 522
25. G. Haran, R. Cohen, L.K. Bar, and Y. Barenholz Transmembrane ammonium-sulfate gradients in liposomes produce efficient and stable entrapment of amphiphatic weak bases Biochim. Biophys. Acta Biomembr. 1151 1993 201 215
26. H.-I. Chang, and M.-K. Yeh Clinical development of liposome-based drugs: Formulation, characterization, and therapeutic efficacy Int. J. Nanomedicine 7 2012 49 60
27. F. Meunier, H.G. Prentice, and O. Ringdén Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial J. Antimicrob. Chemother. 28 1991 83 91
28. J.A. Olson, J.P. Adler-Moore, G.M. Jensen, J. Schwartz, M.C. Dignani, and R.T. Proffitt Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products Antimicrob. Agents Chemother. 52 2008 259 268
29. E. Rivera Liposomal anthracyclines in metastatic breast cancer: clinical update Oncologist 8 Suppl. 2 2003 3 9
30. J. Park Liposome-based drug delivery in breast cancer treatment Breast Cancer Res. 4 2002 95 99
31. R.L. Hong Liposomal anti-cancer drug researches - The myth of long circulation J. Chin. Oncol. Soc. 20 2004 10 21
32. R.K. Chowdhary, I. Shariff, and D. Dolphin Drug release characteristics of lipid based benzoporphyrin derivative J. Pharm. Pharm. Sci. 6 2003 13 19
33. A. Fahr, P. van Hoogevest, S. May, N. Bergstrand, and S. ML Leigh Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery Eur. J. Pharm. Sci. 26 2005 251 265
34. V. Usonis, V. Bakasenas, R. Valentelis, G. Katiliene, D. Vidzeniene, and C. Herzog Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal) Vaccine 21 2003 4588 4592
35. C. Herzog, K. Hartmann, V. Kunzi, O. Kursteiner, R. Mischler, H. Lazar, and R. Gluck Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine Vaccine 27 2009 4381 4387
36. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomedicine 1 2006 297 315
37. K.M. Wasan, and G. Lopez-Berestein Characteristics of lipid-based formulations that influence their biological behavior in the plasma of patients Clin. Infect. Dis. 23 1996 1126 1138
38. L.S. Guo Amphotericin B colloidal dispersion: an improved antifungal therapy Adv. Drug Deliv. Rev. 47 2001 149 163
39. J.V. Natarajan, A. Darwitan, V.A. Barathi, M. Ang, H.M. Htoon, F. Boey, K.C. Tam, T.T. Wong, and S.S. Venkatraman Sustained drug release in nanomedicine: A long-acting nanocarrier-based formulation for glaucoma ACS Nano 8 2014 419 429
40. N.T. Huynh, C. Passirani, P. Saulnier, and J.P. Benoit Lipid nanocapsules: a new platform for nanomedicine Int. J. Pharm. 379 2009 201 209
41. J.V. Natarajan, M. Ang, A. Darwitan, S. Chattopadhyay, T.T. Wong, and S.S. Venkatraman Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye Int. J. Nanomedicine 7 2012
42. G.J. Charrois, and T.M. Allen Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer Biochim. Biophys. Acta 1663 2004 167 177
43. U. Bhardwaj, and D.J. Burgess Physicochemical properties of extruded and non-extruded liposomes containing the hydrophobic drug dexamethasone Int. J. Pharm. 388 2010 181 189
44. N. Dos Santos, K.A. Cox, C.A. McKenzie, F. van Baarda, R.C. Gallagher, G. Karlsson, K. Edwards, L.D. Mayer, C. Allen, and M.B. Bally pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol Biochim. Biophys. Acta Biomembr. 1661 2004 47 60
45. J. Gubernator Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity Expert Opin. Drug Deliv. 8 2011 565 580
46. D.D. Lasic, B. Ceh, M.C.A. Stuart, L. Guo, P.M. Frederik, and Y. Barenholz Transmembrane gradient driven phase-transitions within vesicles - lessons for drug delivery Biochim. Biophys. Acta Biomembr. 1239 1995 145 156
47. N. Maurer, K.F. Wong, M.J. Hope, and P.R. Cullis Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a H-1-NMR study Biochim. Biophys. Acta Biomembr. 1374 1998 9 20
48. M.J. Johnston, S.C. Semple, S.K. Klimuk, K. Edwards, M.L. Eisenhardt, E.C. Leng, G. Karlsson, D. Yanko, and P.R. Cullis Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations Biochim. Biophys. Acta Biomembr. 1758 2006 55 64
49. M.J. Johnston, K. Edwards, G. Karlsson, and P.R. Cullis Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations J. Liposome Res. 18 2008 145 157
50. M. Abrishami, S.Z. Ganavati, D. Soroush, M. Rouhbakhsh, M.R. Jaafari, and B. Malaekeh-Nikouei Preparation, characterization, and in vivo evaluation of nanoliposomes-encapsulated bevacizumab (avastin) for intravitreal administration Retina J. Retin. Vit. Dis. 29 2009 699 703
51. A. Bochot, and E. Fattal Liposomes for intravitreal drug delivery: A state of the art J. Control. Release 161 2012 628 634
52. Y. Katanasaka, T. Ida, T. Asai, K. Shimizu, F. Koizumi, N. Maeda, K. Baba, and N. Oku Antiangiogenic cancer therapy using tumor vasculature-targeted liposomes encapsulating 3-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one, SU5416 Cancer Lett. 270 2008 260 268
53. X.-p. Gao, Y. Noda, I. Rubinstein, and S. Paul Vasoactive intestinal peptide encapsulated in liposomes: Effects on systemic arterial blood pressure Life Sci. 54 1994 PL247 PL252
54. S. Hwang, Y. Maitani, X.-R. Qi, K. Takayama, and T. Nagai Remote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methods Int. J. Pharm. 179 1999 85 95
55. P. Kallinteri, S.G. Antimisiaris, D. Karnabatidis, C. Kalogeropoulou, I. Tsota, and D. Siablis Dexamethasone incorporating liposomes: an in vitro study of their applicability as a slow releasing delivery system of dexamethasone from covered metallic stents Biomaterials 23 2002 4819 4826
56. J. Liu, H. Lee, M. Huesca, A. Young, and C. Allen Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy Cancer Chemother. Pharmacol. 58 2006 306 318
57. Q. Ye, J. Asherman, M. Stevenson, E. Brownson, and N.V. Katre DepoFoam(tm) technology: a vehicle for controlled delivery of protein and peptide drugs J. Control. Release 64 2000 155 166
58. C. Schwarz, W. Mehnert, J.S. Lucks, and R.H. Müller Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization J. Control. Release 30 1994 83 96
59. M.R. Gasco, R. Cavalli, and M.E. Carlotti Timolol in lipospheres Die Pharmazie 47 1992 119 121
60. C. Pardeshi, P. Rajput, V. Belgamwar, A. Tekade, G. Patil, K. Chaudhary, and A. Sonje Solid lipid based nanocarriers: an overview Acta Pharm. 62 2012 433 472
61. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
62. R.H. Müller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 2002 121 128
63. V. Jenning, K. Mäder, and S.H. Gohla Solid lipid nanoparticles (SLN) based on binary mixtures of liquid and solid lipids: a (1)H-NMR study Int. J. Pharm. 205 2000 15 21
64. S. Das, W.K. Ng, and R.B.H. Tan Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur. J. Pharm. Sci. 47 2012 139 151
65. A. zur Mühlen, C. Schwarz, and W. Mehnert Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism Eur. J. Pharm. Biopharm. 45 1998 149 155
66. A.J. Almeida, and E. Souto Solid lipid nanoparticles as a drug delivery system for peptides and proteins Adv. Drug Deliv. Rev. 59 2007 478 490
67. S. Saraf, D. Mishra, A. Asthana, R. Jain, S. Singh, and N.K. Jain Lipid microparticles for mucosal immunization against hepatitis B Vaccine 24 2006 45 56
68. I. Ribeiro Dos Santos, J. Richard, B. Pech, C. Thies, and J.P. Benoit Microencapsulation of protein particles within lipids using a novel supercritical fluid process Int. J. Pharm. 242 2002 69 78
69. A.J. Almeida, S. Runge, and R.H. Müller Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters Int. J. Pharm. 149 1997 255 265
70. M. Garcia-Fuentes, D. Torres, and M.J. Alonso New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin Int. J. Pharm. 296 2005 122 132
71. R.H. Müller, S. Runge, V. Ravelli, W. Mehnert, A.F. Thünemann, and E.B. Souto Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals Int. J. Pharm. 317 2006 82 89
72. M. Trotta, R. Cavalli, M.E. Carlotti, L. Battaglia, and F. Debernardi Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique Int. J. Pharm. 288 2005 281 288
73. N. Zhang, Q. Ping, G. Huang, W. Xu, Y. Cheng, and X. Han Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin Int. J. Pharm. 327 2006 153 159
74. H. Reithmeier, J. Herrmann, and A. Göpferich Development and characterization of lipid microparticles as a drug carrier for somatostatin Int. J. Pharm. 218 2001 133 143
75. F.Q. Hu, Y. Hong, and H. Yuan Preparation and characterization of solid lipid nanoparticles containing peptide Int. J. Pharm. 273 2004 29 35
76. H. Yuan, S.-P. Jiang, Y.-Z. Du, J. Miao, X.-G. Zhang, and F.-Q. Hu Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles Colloids Surf. B: Biointerfaces 70 2009 248 253
77. S. Li, B. Zhao, F. Wang, M. Wang, S. Xie, S. Wang, C. Han, L. Zhu, and W. Zhou Yak interferon-alpha loaded solid lipid nanoparticles for controlled release Res. Vet. Sci. 88 2010 148 153
78. A. Kumari, S.K. Yadav, and S.C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf. B: Biointerfaces 75 2010 1 18
79. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J. Control. Release 70 2001 1 20
80. M.L. Hans, and A.M. Lowman Biodegradable nanoparticles for drug delivery and targeting Curr. Opinion Solid State Mater. Sci. 6 2002 319 327
81. R.C. Mundargi, V.R. Babu, V. Rangaswamy, P. Patel, and T.M. Aminabhavi Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives J. Control. Release 125 2008 193 209
82. E. Leo, B. Brina, F. Forni, and M.A. Vandelli In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form Int. J. Pharm. 278 2004 133 141
83. T.W. Chitosan Nanoparticles: A promising system for drug delivery Naresuan Univ. J. 11 2003 51 66
84. C. Pinto Reis, R.J. Neufeld, A.J. Ribeiro, and F. Veiga Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles Nanomedicine 2 2006 8 21
85. M.F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, and C. Vigneron Preparation and characterization of protein C-loaded PLA nanoparticles J. Control. Release 60 1999 179 188
86. D.K. Sahana, G. Mittal, V. Bhardwaj, and M.N. Kumar PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug J. Pharm. Sci. 97 2008 1530 1542
87. J.M. Barichello, M. Morishita, K. Takayama, and T. Nagai Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Dev. Ind. Pharm. 25 1999 471 476
88. L. Mu, and S.S. Feng A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS J. Control. Release 86 2003 33 48
89. V. Labhasetwar, C. Song, W. Humphrey, R. Shebuski, and R.J. Levy Arterial uptake of biodegradable nanoparticles: effect of surface modifications J. Pharm. Sci. 87 1998 1229 1234
90. K. Derakhshandeh, M. Erfan, and S. Dadashzadeh Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics Eur. J. Pharm. Biopharm. 66 2007 34 41
91. H. Murakami, M. Kobayashi, H. Takeuchi, and Y. Kawashima Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method Int. J. Pharm. 187 1999 143 152
92. A. Beletsi, P. Klepetsanis, D.S. Ithakissios, S. Kounias, A. Stavropoulos, and K. Avgoustakis Simultaneous optimization of cisplatin-loaded PLGA-mPEG nanoparticles with regard to their size and drug encapsulation Curr. Nanosci. 4 2008 173 178
93. M.P. Desai, J.M. Hilfinger, G.L. Amidon, R.J. Levy, and V. Labhasetwar Immune response with biodegradable nanospheres and alum: studies in rabbits using staphylococcal enterotoxin B-toxoid J. Microencapsul. 17 2000 215 225
94. H. Cohen, R.J. Levy, J. Gao, I. Fishbein, V. Kousaev, S. Sosnowski, S. Slomkowski, and G. Golomb Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles Gene Ther. 7 2000 1896 1905
95. S.E. Dunn, A.G.A. Coombes, M.C. Garnett, S.S. Davis, M.C. Davies, and L. Illum In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers J. Control. Release 44 1997 65 76
96. F. De Jaeghere, E. Allémann, J.-C. Leroux, W. Stevels, J. Feijen, E. Doelker, and R. Gurny Formulation and lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) nanoparticles: Influence on physical stability and in vitro cell uptake Pharm. Res. 16 1999 859 866
97. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603
98. M.T. Peracchia, C. Vauthier, C. Passirani, P. Couvreur, and D. Labarre Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles Life Sci. 61 1997 749 761
99. J.-C. Leroux, E. Allémann, F. De Jaeghere, E. Doelker, and R. Gurny Biodegradable nanoparticles - From sustained release formulations to improved site specific drug delivery J. Control. Release 39 1996 339 350
100. E. Allemann, J.C. Leroux, R. Gurny, and E. Doelker In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure Pharm. Res. 10 1993 1732 1737
101. P. Prabu, A.A. Chaudhari, N. Dharmaraj, M.S. Khil, S.Y. Park, and H.Y. Kim Preparation, characterization, in-vitro drug release and cellular uptake of poly(caprolactone) grafted dextran copolymeric nanoparticles loaded with anticancer drug J. Biomed. Mater. Res. A 90 2009 1128 1136
102. F. Danhier, N. Lecouturier, B. Vroman, C. Jérôme, J. Marchand-Brynaert, O. Feron, and V. Préat Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation J. Control. Release 133 2009 11 17
103. C. Liang, Y. Yang, Y. Ling, Y. Huang, T. Li, and X. Li Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma Bioorg. Med. Chem. 19 2011 4057 4066
104. C.X. Song, V. Labhasetwar, H. Murphy, X. Qu, W.R. Humphrey, R.J. Shebuski, and R.J. Levy Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery J. Control. Release 43 1997 197 212
105. L.A. Guzman, V. Labhasetwar, C. Song, Y. Jang, A.M. Lincoff, R. Levy, and E.J. Topol Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty Circulation 94 1996 1441 1448
106. T. Suzuki, G. Kopia, S. Hayashi, L.R. Bailey, G. Llanos, R. Wilensky, B.D. Klugherz, G. Papandreou, P. Narayan, M.B. Leon, A.C. Yeung, F. Tio, P.S. Tsao, R. Falotico, and A.J. Carter Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model Circulation 104 2001 1188 1193
107. E. Grube, S. Silber, K.E. Hauptmann, R. Mueller, L. Buellesfeld, U. Gerckens, and M.E. Russell TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation 107 2003 38 42
108. S. Venkatraman, and F. Boey Release profiles in drug-eluting stents: issues and uncertainties J. Control. Release 120 2007 149 160
109. M. Delcea, H. Möhwald, and A.G. Skirtach Stimuli-responsive LbL capsules and nanoshells for drug delivery Adv. Drug Deliv. Rev. 63 2011 730 747
110. H.I. Labouta, and M. Schneider Tailor-made biofunctionalized nanoparticles using layer-by-layer technology Int. J. Pharm. 395 2010 236 242
111. V. Vergaro, F. Scarlino, C. Bellomo, R. Rinaldi, D. Vergara, M. Maffia, F. Baldassarre, G. Giannelli, X. Zhang, Y.M. Lvov, and S. Leporatti Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells Adv. Drug Deliv. Rev. 63 2011 847 864
112. K. Ariga, Y.M. Lvov, K. Kawakami, Q. Ji, and J.P. Hill Layer-by-layer self-assembled shells for drug delivery Adv. Drug Deliv. Rev. 63 2011 762 771
113. Z.S. Haidar, R.C. Hamdy, and M. Tabrizian Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes Biomaterials 29 2008 1207 1215
114. Y. Fukui, and K. Fujimoto The preparation of sugar polymer-coated nanocapsules by the layer-by-layer deposition on the liposome Langmuir 25 2009 10020 10025
115. Z.J. Deng, S.W. Morton, E. Ben-Akiva, E.C. Dreaden, K.E. Shopsowitz, and P.T. Hammond Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment ACS Nano 7 2013 9571 9584
116. W. Feng, X. Zhou, C. He, K. Qiu, W. Nie, L. Chen, H. Wang, X. Mo, and Y. Zhang Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: layer thickness-dependent release profiles and biocompatibility J. Mater. Chem. B 1 2013 5886 5898
117. U. Bazylinska, R. Skrzela, K. Szczepanowicz, P. Warszynski, and K.A. Wilk Novel approach to long sustained multilayer nanocapsules: influence of surfactant head groups and polyelectrolyte layer number on the release of hydrophobic compounds Soft Matter 7 2011 6113 6124
118. U. Bazylińska, P. Warszyński, and K.A. Wilk Influence of pH upon in vitro sustained dye-release from oil-core nanocapsules with multilayer shells Colloids Surf. A Physicochem. Eng. Asp. 413 2012 266 272
119. U. Bazylińska, R. Skrzela, M. Piotrowski, K. Szczepanowicz, P. Warszyński, and K.A. Wilk Influence of dicephalic ionic surfactant interactions with oppositely charged polyelectrolyte upon the in vitro dye release from oil core nanocapsules Bioelectrochemistry 87 2012 147 153
120. J. Zhou, S. Moya, L. Ma, C. Gao, and J. Shen Polyelectrolyte coated PLGA nanoparticles: templation and release behavior Macromol. Biosci. 9 2009 326 335
121. C. Nugraha, M. Bora, and S.S. Venkatraman Release retardation of model protein on polyelectrolyte-coated PLGA nano- and microparticles PLoS ONE 9 2014 e92393
122. R. Luo, B. Neu, and S.S. Venkatraman Surface functionalization of nanoparticles to control cell interactions and drug release Small 8 2012 2585 2594
123. S.W. Morton, Z. Poon, and P.T. Hammond The architecture and biological performance of drug-loaded LbL nanoparticles Biomaterials 34 2013 5328 5335
124. W. Liu, G. Chen, G. He, Z. He, and Z. Qian Sacrificial functional polystyrene template to prepare chitosan nanocapsules and in vitro drug release properties J. Mater. Sci. 46 2011 6758 6765
125. Y. Wang, V. Bansal, A.N. Zelikin, and F. Caruso Templated synthesis of single-component polymer capsules and their application in drug delivery Nano Lett. 8 2008 1741 1745
126. M. Huang, and C. Berkland Controlled release of repifermin from polyelectrolyte complexes stimulates endothelial cell proliferation J. Pharm. Sci. 98 2009 268 280
127. M. Petchsangsai, W. Sajomsang, P. Gonil, O. Nuchuchua, B. Sutapun, S. Puttipipatkhachorn, and U.R. Ruktanonchai A water-soluble methylated N-(4-N, N-dimethylaminocinnamyl) chitosan chloride as novel mucoadhesive polymeric nanocomplex platform for sustained-release drug delivery Carbohydr. Polym. 83 2011 1263 1273
128. V.E. Santo, M.E. Gomes, J.F. Mano, and R.L. Reis Chitosan-chondroitin sulphate nanoparticles for controlled delivery of platelet lysates in bone regenerative medicine J. Tissue Eng. Regen. Med. 6 Suppl. 3 2012 s47 s59
129. Y. Xiong, J. Qi, and P. Yao Amphiphilic cholic-acid-modified dextran sulfate and its application for the controlled delivery of superoxide dismutase Macromol. Biosci. 12 2012 515 524
130. R. Guo, L. Chen, S. Cai, Z. Liu, Y. Zhu, W. Xue, and Y. Zhang Novel alginate coated hydrophobically modified chitosan polyelectrolyte complex for the delivery of BSA J. Mater. Sci. Mater. Med. 24 2013 2093 2100
131. S. Raveendran, A.C. Poulose, Y. Yoshida, T. Maekawa, and D.S. Kumar Bacterial exopolysaccharide based nanoparticles for sustained drug delivery, cancer chemotherapy and bioimaging Carbohydr. Polym. 91 2013 22 32
132. Y.S. Jung, W. Park, and K. Na Temperature-modulated noncovalent interaction controllable complex for the long-term delivery of etanercept to treat rheumatoid arthritis J. Control. Release 171 2013 143 151
133. X.Y. Zhao, Y.J. Zhu, F. Chen, B.Q. Lu, C. Qi, J. Zhao, and J. Wu Calcium phosphate hybrid nanoparticles: self-assembly formation, characterization, and application as an anticancer drug nanocarrier Chem. Asian. J. 8 2013 1306 1312
134. P. Fattahi, A. Borhan, and M.R. Abidian Microencapsulation of chemotherapeutics into monodisperse and tunable biodegradable polymers via electrified liquid jets: Control of size, shape, and drug release Adv. Mater. 25 2013 4555 4560
135. J.A. Champion, Y.K. Katare, and S. Mitragotri Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers J. Control. Release 121 2007 3 9
136. J.A. Champion, and S. Mitragotri Role of target geometry in phagocytosis Proc. Natl. Acad. Sci. U. S. A. 103 2006 4930 4934
137. M.R. Abidian, D.H. Kim, and D.C. Martin Conducting-polymer nanotubes for controlled drug release Adv. Mater. 18 2006 405 409
138. Z. Liu, K. Chen, C. Davis, S. Sherlock, Q. Cao, X. Chen, and H. Dai Drug delivery with carbon nanotubes for in vivo cancer treatment Cancer Res. 68 2008 6652 6660
139. Z. Liu, X. Sun, N. Nakayama-Ratchford, and H. Dai Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery ACS Nano 1 2007 50 56
140. Y. Liu, Y. Zhao, B. Sun, and C. Chen Understanding the toxicity of carbon nanotubes Acc. Chem. Res. 46 2013 702 713